Spotlight on buprenorphine/naloxone in the treatment of opioid dependence.

CNS drugs

Volumn 23, Issue 10, 2009, Pages 899-902

  Orman, Jennifer S ^a   Keating, Gillian M ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; NALOXONE;

DRUG COMBINATION; HUMAN; METABOLISM; METHODOLOGY; OPIATE ADDICTION; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

BUPRENORPHINE; DRUG COMBINATIONS; HUMANS; NALOXONE; OPIOID-RELATED DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 77749248243     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/11203740-000000000-00000     Document Type: Review

References (25)